1. Home
  2. KVHI vs MCRB Comparison

KVHI vs MCRB Comparison

Compare KVHI & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$5.99

Market Cap

118.4M

Sector

Technology

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$8.65

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVHI
MCRB
Founded
1978
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.4M
139.7M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
KVHI
MCRB
Price
$5.99
$8.65
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$14.33
AVG Volume (30 Days)
45.8K
93.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.63
100.00
EPS
N/A
2.40
Revenue
$9,622,000.00
$126,325,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$14.15
N/A
P/E Ratio
N/A
$3.43
Revenue Growth
3.82
1672.24
52 Week Low
$4.80
$0.36
52 Week High
$7.71
$29.98

Technical Indicators

Market Signals
Indicator
KVHI
MCRB
Relative Strength Index (RSI) 42.88 26.09
Support Level $5.80 $7.12
Resistance Level $6.27 $8.49
Average True Range (ATR) 0.39 1.13
MACD -0.01 -0.42
Stochastic Oscillator 30.93 5.42

Price Performance

Historical Comparison
KVHI
MCRB

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: